<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51672-4240-6
</NDCCode>
<PackageDescription>
9 PACKET in 1 CARTON (51672-4240-6) / 1 POWDER, FOR SOLUTION in 1 PACKET (51672-4240-8)
</PackageDescription>
<NDC11Code>
51672-4240-06
</NDC11Code>
<ProductNDC>
51672-4240
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Diclofenac Potassium
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Diclofenac Potassium
</NonProprietaryName>
<DosageFormName>
POWDER, FOR SOLUTION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20240624
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA218011
</ApplicationNumber>
<LabelerName>
Taro Pharmaceuticals U.S.A., Inc.
</LabelerName>
<SubstanceName>
DICLOFENAC POTASSIUM
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2024-10-15
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20240624
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>